Browsing by Autor "Igor C. Almeida"

Filter results by typing the first few letters
Now showing 1 - 4 of 4
  • Thumbnail Image
    Item type: Item ,
    Big is not better: Comparing two alpha-Gal-bearing glycotopes in neoglycoproteins as biomarkers for Leishmania (Viannia) braziliensis infection
    (Elsevier BV, 2023) Alba L. Montoya; Eileni R. Gil; Irodiel Vinales; Igor L. Estevao; Paola Taboada; Mary Cruz Torrico; Faustino Torrico; Jorge D. Marco; Igor C. Almeida; Katja Michael
  • Thumbnail Image
    Item type: Item ,
    New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial
    (Elsevier BV, 2021) Faustino Torrico; Joaquím Gascón; Fabiana Barreira; Bethania Blum; Igor C. Almeida; Cristina Alonso‐Vega; Tayná Barboza; Graeme Bilbe; Erika Correia; Wilson García
    For the Spanish translation of the abstract see Supplementary Materials section.
  • Thumbnail Image
    Item type: Item ,
    Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus
    (Public Library of Science, 2020) Julio Alonso-Padilla; Marcelo Abril; Belkisyolé Alarcón de Noya; Igor C. Almeida; Andrea Angheben; Tania Araujo Jorge; Eric Chatelain; Mónica I. Esteva; Joaquím Gascón; Mario J. Grijalva
    ISGlobal work is supported by the Departament d’Universitats i Recerca de la Generalitat de Catalunya, Spain (AGAUR; 017SGR00924) and by the Instituto de Salud Carlos III (ISCIII) RICET Network for Cooperative Research in Tropical Diseases (ISCIII; RD16/0027/0004 - PI1290) and FEDER. MJP research is supported by the Ministry of Health, Government of Catalonia (PERIS 2016-2010 SLT008/18/00132). ICA, JG, and FT are supported by the grant number U01AI129783 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). ICA is also partly supported by the grant number 5U54MD007592 from the National Institute on Minority Health and Health Disparities (NIMHD), NIH. MCL and MCT were supported by ISCIII RICET grant RD16/0027/0005 - PI1290 and FEDER and by grants SAF2016-81003-R and SAF2016-80998-R from the Spanish “Programa Estatal I+D+i (MINECO)”. AA's work was supported by the Italian Ministry of Health “Fondi Ricerca Corrente - Linea 3, progetto 9” to IRCCS Sacro Cuore Don Calabria Hospital. JR was supported by CONACyT Fossis grant #261006. The Drugs for Neglected Diseases initiative (DNDi) is grateful to its donors, public and private, who have provided funding to DNDi since its inception in 2003. A full list of DNDi's donors can be found at http://www.dndi.org/donate/donors/. FIND is grateful to its donors, public and private, who have helped bring innovative new diagnostics for diseases of poverty. A full list of FIND’s donors can be found at: https://www.finddx.org/partners-donors/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  • Thumbnail Image
    Item type: Item ,
    Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial
    (Elsevier BV, 2018) Faustino Torrico; Joaquím Gascón; Lourdes Ortiz; Cristina Alonso‐Vega; María‐Jesús Pinazo; Alejandro G. Schijman; Igor C. Almeida; Fabiana Alves; Nathalie Strub‐Wourgaft; Isabela Ribeiro